# OTX-14-006: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye

> **NCT02468700** · PHASE2 · COMPLETED · sponsor: **Ocular Therapeutix, Inc.** · enrollment: 43 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Dexamethasone
- **OTHER:** Placebo Vehicle

## Key facts

- **NCT ID:** NCT02468700
- **Lead sponsor:** Ocular Therapeutix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-08
- **Final completion:** 2015-11
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2018-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02468700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02468700, "OTX-14-006: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02468700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*